Natriuretic peptide(BNP)and N-terminal pro-B-type natriuretic peptide(NT-proBNP)are widely used in the screening and diagnosis of heart failure,and then through intervention,to prevent the occurrence of heart failure,it is a biomarker of heart failure.In patients with heart failure,natriuretic peptide monitoring before discharge is helpful in assessing the risk of cardiovascular events after discharge.For a variety of other cardiovascular diseases,including acute coronary syndrome and atrial fibrillation,will also lead to increased levels of natriuretic peptide.Therefore,BNP and NT-proBNP will be the active area of research in the clinic.
维普
万方数据